Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients

Title
Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients
Authors
Keywords
B cells, Diagnostic medicine, T cells, Drug therapy, Magnetic resonance imaging, Fibrosis, Lesions, Radiology and imaging
Journal
PLoS One
Volume 12, Issue 9, Pages e0183844
Publisher
Public Library of Science (PLoS)
Online
2017-09-16
DOI
10.1371/journal.pone.0183844

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search